1Braak H;Braak E.Neuropathological stageing of Alzheimer-related changes,1991(04).
2Irizarry MC;McNamara M.Appswe transgenic mice develop age-related Aβdeposits and neuropil abnormalities,but no neuronal loss in CA1[J],1997(09).
3Small GW;Rabins PV;Barry PP.Diagnosis and treatment of Alzheimer diseaseand related disorders.Consensus statement of the American Associationfor Geriatric Psychiatry,the Alzheimer's Association,and the AmericanGeriatrics Society[J],1997.
4Corder EH;Saunders AM;Strittmatter WJ.Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families[J],1993.
5Nyabi O;Bentahir M;Horre K.Presenilins mutated at Asp-257or Asp-385 restore Pen-2 expression and Nicastrin glyecosylation but remain catalytically inactive in the absence of wild type Presenilin[J],2003(44).
6Tanzi RE;Bertram L.Twenty years of the Alzheimer's disease amyloid hypothesis:a genetic perspective[J],2005(4).
7Edbauer D;Winkler E;Regula JT;Pesold B Steiner H Haass C.Reconstitution of gamma-secretase activity[J],2003(5).
8Lambert M P;Barlow A K;Chromy B A;Edwards C, Freed R, Liosatos M, Morgan T E, Rozovsky I, Trommer B, Viola K L, Wals P, Zhang C, Finch C E, Krafft G A, Klein W L.Diffusible,nonfibrillar ligands derived from A beta(1-42) are potent central nervous system neurotoxins[J],1998(11).
9Torreilles F;Touchon J.Pathogenic theories and intrathecal analysis of the sporadic from of Alzheimer's disease[J],2002(3).
10Masters CL;Simms G;Weinman NA;Beyreuther K..Amyloid plaque core protein in Alzheimer disease and Down syndrome[J],1985(12).
9Alzheimer' Association,Alzheimer's Association Report:2 0 1 2 Alzheimer's disease facts and figures[J].Alzheimers Dement,2012,8(2):131-168.
10Glenner GG,Wong CW.Alzheimer's disease:initial report of the purification and characterization of a novel cerebrovascular amyloid protein[J].Biochem Biophys Res Commun,1984,120:885-90.
